Unravelling Atrioventricular Block Risk in Inflammatory Diseases: Systemic Inflammation Acutely Delays Atrioventricular Conduction via a Cytokine-Mediated Inhibition of Connexin43 Expression.

PR‐interval atrioventricular blocks atrioventricular conduction cardiac electrical remodelling connexin43 interleukin‐6 systemic inflammation

Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
02 11 2021
Historique:
pubmed: 30 10 2021
medline: 4 3 2022
entrez: 29 10 2021
Statut: ppublish

Résumé

Background Recent data suggest that systemic inflammation can negatively affect atrioventricular conduction, regardless of acute cardiac injury. Indeed, gap-junctions containing connexin43 coupling cardiomyocytes and inflammation-related cells (macrophages) are increasingly recognized as important factors regulating the conduction in the atrioventricular node. The aim of this study was to evaluate the acute impact of systemic inflammatory activation on atrioventricular conduction, and elucidate underlying mechanisms. Methods and Results We analyzed: (1) the PR-interval in patients with inflammatory diseases of different origins during active phase and recovery, and its association with inflammatory markers; (2) the existing correlation between connexin43 expression in the cardiac tissue and peripheral blood mononuclear cells (PBMC), and the changes occurring in patients with inflammatory diseases over time; (3) the acute effects of interleukin(IL)-6 on atrioventricular conduction in an in vivo animal model, and on connexin43 expression in vitro. In patients with elevated C-reactive protein levels, atrioventricular conduction indices are increased, but promptly normalized in association with inflammatory markers reduction, particularly IL-6. In these subjects, connexin43 expression in PBMC, which is correlative of that measured in the cardiac tissue, inversely associated with IL-6 changes. Moreover, direct IL-6 administration increased atrioventricular conduction indices in vivo in a guinea pig model, and IL-6 incubation in both cardiomyocytes and macrophages in culture, significantly reduced connexin43 proteins expression. Conclusions The data evidence that systemic inflammation can acutely worsen atrioventricular conduction, and that IL-6-induced down-regulation of cardiac connexin43 is a mechanistic pathway putatively involved in the process. Though reversible, these alterations could significantly increase the risk of severe atrioventricular blocks during active inflammatory processes.

Identifiants

pubmed: 34713715
doi: 10.1161/JAHA.121.022095
pmc: PMC8751850
doi:

Substances chimiques

Connexin 43 0
Cytokines 0
Interleukin-6 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e022095

Références

Front Cardiovasc Med. 2019 Dec 03;6:181
pubmed: 31850376
Heart. 2016 May;102(9):672-80
pubmed: 26879241
JAMA. 2009 Jun 24;301(24):2571-7
pubmed: 19549974
Histol Histopathol. 2003 Apr;18(2):359-69
pubmed: 12647785
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Heart Rhythm. 2007 Feb;4(2):170-4
pubmed: 17275752
Eur Heart J. 2014 Jan;35(2):123-9
pubmed: 23677846
Basic Res Cardiol. 2016 Nov;111(6):63
pubmed: 27660282
PLoS One. 2018 Dec 6;13(12):e0208321
pubmed: 30521586
Sci Rep. 2020 Feb 13;10(1):2551
pubmed: 32054960
Immunology. 2000 Apr;99(4):578-90
pubmed: 10792506
Circ Arrhythm Electrophysiol. 2020 Aug;13(8):e008627
pubmed: 32654514
Cell. 2017 Apr 20;169(3):510-522.e20
pubmed: 28431249
Clin Cardiol. 2017 Oct;40(10):865-872
pubmed: 28605034
Int J Biol Sci. 2018 Nov 2;14(14):1993-2002
pubmed: 30585263
J Mol Cell Cardiol. 2016 Feb;91:114-22
pubmed: 26739214
Indian Pacing Electrophysiol J. 2020 Sep - Oct;20(5):211-212
pubmed: 32822746
J Electrocardiol. 2012 Jan-Feb;45(1):66-9
pubmed: 21784432
Heart Rhythm. 2014 Jan;11(1):93-8
pubmed: 24096163
Sci Rep. 2020 Jul 17;10(1):11883
pubmed: 32681032
Biosci Rep. 2018 Mar 29;38(2):
pubmed: 29535277
Eur Heart J. 2011 Aug;32(15):1875-80
pubmed: 21606074
Nat Rev Immunol. 2018 Dec;18(12):733-744
pubmed: 30228378
J Am Heart Assoc. 2019 Aug 20;8(16):e011006
pubmed: 31423933
J Am Coll Cardiol. 2014 Jun 3;63(21):2261-9
pubmed: 24703920
N Engl J Med. 2017 Jul 6;377(1):84-86
pubmed: 28679094
Heart Rhythm. 2020 Sep;17(9):1434-1438
pubmed: 32535142
Cardiovasc Res. 2004 May 1;62(2):357-67
pubmed: 15094355
Pharmacol Ther. 2013 Aug;139(2):260-88
pubmed: 23612425
Heart Rhythm. 2013 Feb;10(2):297-304
pubmed: 23085482
Cardiovasc Res. 2008 Oct 1;80(1):9-19
pubmed: 18519446
Nat Biotechnol. 2017 Jan;35(1):56-68
pubmed: 27941801
J Clin Invest. 2000 Jan;105(2):161-71
pubmed: 10642594
Br J Pharmacol. 2009 Sep;158(1):198-208
pubmed: 19719782
Circ Arrhythm Electrophysiol. 2021 Mar;14(3):e009458
pubmed: 33554620
J Am Coll Cardiol. 2017 Jul 18;70(3):371-372
pubmed: 28705319
Pacing Clin Electrophysiol. 2020 Oct;43(10):1199-1204
pubmed: 32820823
Circ Res. 2000 Apr 14;86(7):723-8
pubmed: 10764404
Front Cardiovasc Med. 2015 May 27;2:26
pubmed: 26798623
Proc Natl Acad Sci U S A. 1998 Mar 17;95(6):2979-84
pubmed: 9501201
Can J Cardiol. 2017 May;33(5):674-681
pubmed: 28449838
Heart Rhythm. 2016 Dec;13(12):2379-2387
pubmed: 27639456
J Am Heart Assoc. 2018 Nov 20;7(22):e010595
pubmed: 30571503
J Immunol. 2011 Sep 15;187(6):3121-32
pubmed: 21844382
Am J Physiol Heart Circ Physiol. 2007 Mar;292(3):H1561-7
pubmed: 17122196
Compr Physiol. 2015 Jul 1;5(3):1423-64
pubmed: 26140724
Cytokine. 1999 Mar;11(3):216-24
pubmed: 10209069
Eur Heart J. 2017 Jun 7;38(22):1717-1727
pubmed: 27252448
Front Cardiovasc Med. 2019 Dec 10;6:183
pubmed: 31921897
J Geriatr Cardiol. 2019 Mar;16(3):259-264
pubmed: 31080468
Front Physiol. 2018 Feb 07;9:80
pubmed: 29467678
J Electrocardiol. 2008 Nov-Dec;41(6):491-7
pubmed: 18817925
Circ Arrhythm Electrophysiol. 2020 Oct;13(10):e009023
pubmed: 32931707
Cardiovasc Ther. 2020 Nov 17;2020:5925342
pubmed: 33294032
Circ Arrhythm Electrophysiol. 2020 Sep;13(9):e008791
pubmed: 32702997
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1256-C1267
pubmed: 31577512
Heart Rhythm. 2020 Sep;17(9):1439-1444
pubmed: 32585191
Circ Arrhythm Electrophysiol. 2020 Jun;13(6):e008719
pubmed: 32434385
N Engl J Med. 1986 Nov 6;315(19):1183-7
pubmed: 3762641
Ann Noninvasive Electrocardiol. 2001 Apr;6(2):92-7
pubmed: 11333165
Nat Rev Dis Primers. 2019 Aug 16;5(1):56
pubmed: 31420554
Int J Mol Sci. 2019 May 19;20(10):
pubmed: 31109146
Physiol Res. 2020 Nov 16;69(5):813-822
pubmed: 32901500
Toxicol Sci. 2003 Dec;76(2):437-42
pubmed: 14600288
Nat Rev Immunol. 2019 Jan;19(1):63-64
pubmed: 30552387
Heart Vessels. 2020 Jul;35(7):1025-1035
pubmed: 32270355
Immunity. 2014 Jan 16;40(1):91-104
pubmed: 24439267
Circ Cardiovasc Genet. 2014 Aug;7(4):475-81
pubmed: 24850809
Circ J. 2013;77(5):1171-9
pubmed: 23370453
Curr Opin Cardiol. 2012 May;27(3):236-41
pubmed: 22382502
Heart Fail Rev. 2016 Mar;21(2):169-76
pubmed: 26872673
Circulation. 2019 Aug 20;140(8):e333-e381
pubmed: 30586771
Nat Rev Cardiol. 2015 Apr;12(4):230-43
pubmed: 25622848

Auteurs

Pietro Enea Lazzerini (PE)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Maurizio Acampa (M)

Stroke Unit University Hospital of Siena Italy.

Michael Cupelli (M)

VA New York Harbor Healthcare System SUNY Downstate Medical Center New York NY.
NYU School of Medicine New York NY.

Alessandra Gamberucci (A)

Department of Molecular and Developmental Medicine University of Siena Italy.

Ujala Srivastava (U)

VA New York Harbor Healthcare System SUNY Downstate Medical Center New York NY.

Claudio Nanni (C)

Department of Molecular and Developmental Medicine University of Siena Italy.

Iacopo Bertolozzi (I)

Department of Internal Medicine Cardiology Intensive Therapy Unit Nuovo Ospedale San Giovanni di Dio Florence Italy.

Francesca Vanni (F)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Alessandro Frosali (A)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Anna Cantore (A)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Alessandra Cartocci (A)

Department of Medical Biotechnologies University of Siena Italy.

Antonio D'Errico (A)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Viola Salvini (V)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Riccardo Accioli (R)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Decoroso Verrengia (D)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Fabio Salvadori (F)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Aleksander Dokollari (A)

Department of Cardiac Surgery University Hospital of Siena Italy.
Department of Cardiovascular Surgery Saint Michael HospitalUniversity of Toronto Ontario Canada.

Massimo Maccherini (M)

Department of Cardiac Surgery University Hospital of Siena Italy.

Nabil El-Sherif (N)

VA New York Harbor Healthcare System SUNY Downstate Medical Center New York NY.

Franco Laghi-Pasini (F)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Pier Leopoldo Capecchi (PL)

Department of Medical Sciences Surgery and Neurosciences University of Siena Italy.

Mohamed Boutjdir (M)

VA New York Harbor Healthcare System SUNY Downstate Medical Center New York NY.
NYU School of Medicine New York NY.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH